Clinical Trials Logo
  1. Home
  2. Obstructive Sleep Apnea
  3. NCT03868618
  4. Details
NCT03868618 Clinical Trial

Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM)

Obstructive Sleep Apnea Clinical Trial

— DREAM  

Official title:
A Multicenter Study to Assess the Safety and Effectiveness of the Genio Dual-sided Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea in Adults Subjects

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT03868618
Other study ID # CL-GEN-002033
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 14, 2020
Est. completion date February 2028

Study information
Verified date April 2023
Source Nyxoah S.A.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A multicenter study to assess the safety and effectiveness of the Genio dual-sided hypoglossal nerve stimulation system for the treatment of obstructive sleep apnea in adults subjects.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 115
Est. completion date February 2028
Est. primary completion date February 20, 2024
Accepts healthy volunteers No
Gender All
Age group 22 Years to 75 Years
Eligibility Inclusion Criteria: - Body mass index (BMI) limitations - Likely suffer from moderate to severe OSA based on history and physical - Has either not tolerated, has failed or refused positive airway pressure (PAP) treatments - Willing and capable of providing informed consent Exclusion Criteria: - Inadequately treated sleep disorders other than OSA - Significant co-morbidities that contraindicates surgery or general anesthesia

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Genio™ system
The Genio™ device is a permanent implant. It is implanted in the chin area and delivers stimulation to both hypoglossal nerve branches (i.e., the left and right branches). The implant does not include a battery or an embedded software and is externally powered.

Locations
Country Name City State
Australia Institute Breathing and Sleep Austin Hospital Heidelberg Victoria
Australia Hollywood Hospital Nedlands Western Australia
Australia Wollongong Private Hospital Wollongong New South Wales
Belgium Universitair Ziekenhuis Antwerpen Antwerpen
Germany Technische Universität München München
United States Advanced Ear Nose & Throat Associates Atlanta Georgia
United States University of Alabama at Birmingham Birmingham Alabama
United States ENT and Allegy Associates South Florida Boca Raton Florida
United States Harvard/ Massachusetts Eye & Ear Boston Massachusetts
United States CENTA (Center for ENT & Allergy) Carmel Indiana
United States The Ohio State University, Wexner Medical Center Columbus Ohio
United States Ohio Sleep Medicine Institute Dublin Ohio
United States University of Iowa- Institute for Clinical & Translational Science Iowa City Iowa
United States The University of Tennessee Health Science Center- Dept. of Otolaryngology Memphis Tennessee
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Vanderbilt University Medical Center Nashville Tennessee
United States Weill Cornell Medicine Otolaryngology - Head and Neck Surgery New York New York
United States Thomas Jefferson University Department of Otolaryngology Philadelphia Pennsylvania
United States University of Pennsylvania Philadelphia Pennsylvania
United States Virginia Commonwealth University Richmond Virginia
United States University of South Florida-Tampa General Medical Center Tampa Florida

Sponsors (2)
Lead Sponsor Collaborator
Nyxoah S.A. Nyxoah Inc.

Countries where clinical trial is conducted

United States,  Australia,  Belgium,  Germany, 

Outcome
Type Measure Description Time frame Safety issue
Primary Incidence of device-related SAEs Incidence of device-related SAEs recorded during the study for a period of 12 months post-surgery. 12 months
Primary Change in Apnea Hypopnea Index (AHI4%) percentage of responders at 12 months based on AHI4 12 months
Primary Change in Oxyhemoglobin Desaturation Index (ODI4%) percentage of responders at 12 months based on ODI4 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Active, not recruiting NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A
Completed NCT03060915 - Actigraphy Sleep Parameters in Obstructive Sleep Apnea Patient's N/A